Literature DB >> 30713403

Successful Resolution of Left Ventricular Thrombus after ST-Elevation Myocardial Infarction by Edoxaban in a Patient with High Bleeding Risk.

Kei-Ip Cheong1, Wen-Po Chuang1, Yen-Wen Wu1, Shan-Huei Huang1.   

Abstract

Entities:  

Year:  2019        PMID： 30713403      PMCID： PMC6342836          DOI： 10.6515/ACS.201901_35(1).20180912A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  9 in total

Review 1.  2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in Taiwan.

Authors:  Yi-Heng Li; Chih-Yuan Fang; I-Chang Hsieh; Wei-Chun Huang; Tsung-Hsien Lin; Shih-Hsien Sung; Chiung-Zuan Chiu; Chiung-Jen Wu; Kou-Gi Shyu; Po-Yuan Chang; Ching-Chang Fang; Tse-Min Lu; Ching-Pei Chen; Wei-Chen Tai; Chau-Chyun Sheu; Kai-Che Wei; Yi-Hsiu Huang; Hsing-Mei Wu; Juey-Jen Hwang Hwang
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

2.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao; Jeffrey L Anderson; Alice K Jacobs; Jonathan L Halperin; Nancy M Albert; Ralph G Brindis; Mark A Creager; David DeMets; Robert A Guyton; Judith S Hochman; Richard J Kovacs; Frederick G Kushner; E Magnus Ohman; William G Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2012-12-17       Impact factor: 29.690

3.  Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Authors:  Christopher P Cannon; Deepak L Bhatt; Jonas Oldgren; Gregory Y H Lip; Stephen G Ellis; Takeshi Kimura; Michael Maeng; Bela Merkely; Uwe Zeymer; Savion Gropper; Matias Nordaby; Eva Kleine; Ruth Harper; Jenny Manassie; James L Januzzi; Jurrien M Ten Berg; P Gabriel Steg; Stefan H Hohnloser
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

4.  2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.

Authors:  Chern-En Chiang; Tsu-Juey Wu; Kwo-Chang Ueng; Tze-Fan Chao; Kuan-Cheng Chang; Chun-Chieh Wang; Yenn-Jiang Lin; Wei-Hsian Yin; Jen-Yuan Kuo; Wei-Shiang Lin; Chia-Ti Tsai; Yen-Bin Liu; Kun-Tai Lee; Li-Jen Lin; Lian-Yu Lin; Kang-Ling Wang; Yi-Jen Chen; Mien-Cheng Chen; Chen-Chuan Cheng; Ming-Shien Wen; Wen-Jone Chen; Jyh-Hong Chen; Wen-Ter Lai; Chuen-Wang Chiou; Jiunn-Lee Lin; San-Jou Yeh; Shih-Ann Chen
Journal:  J Formos Med Assoc       Date:  2016-11-24       Impact factor: 3.282

5.  Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.

Authors:  Sean D Pokorney; DaJuanicia N Simon; Laine Thomas; Gregg C Fonarow; Peter R Kowey; Paul Chang; Daniel E Singer; Jack Ansell; Rosalia G Blanco; Bernard Gersh; Kenneth W Mahaffey; Elaine M Hylek; Alan S Go; Jonathan P Piccini; Eric D Peterson
Journal:  Am Heart J       Date:  2015-04-01       Impact factor: 4.749

6.  Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis.

Authors:  Flemming Skjøth; Torben Bjerregaard Larsen; Lars Hvilsted Rasmussen; Gregory Y H Lip
Journal:  Thromb Haemost       Date:  2014-02-28       Impact factor: 5.249

Review 7.  A meta-summary of case reports of non-vitamin K antagonist oral anticoagulant use in patients with left ventricular thrombus.

Authors:  Aloysius Sheng-Ting Leow; Ching-Hui Sia; Benjamin Yong-Qiang Tan; Joshua Ping-Yun Loh
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

8.  Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial.

Authors:  Haiyan Xu; Christian T Ruff; Robert P Giugliano; Sabina A Murphy; Francesco Nordio; Indravadan Patel; Minggao Shi; Michele Mercuri; Elliott M Antman; Eugene Braunwald
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

Review 9.  Left ventricular thrombus formation after acute myocardial infarction.

Authors:  Ronak Delewi; Felix Zijlstra; Jan J Piek
Journal:  Heart       Date:  2012-12       Impact factor: 5.994
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.